Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer
Urolithin A increases the NK activity of PBMCs from patients with prostate cancer and healthy subjects, and the AhR may be involved in this capability of urolithin A.
Authors
- А. А. Крашенинников (ORCID: https://orcid.org/0000-0002-9854-7375)
- Vladimir V. Murugin
- Vladimir Rogovskii
- С. В. Попов (ORCID: https://orcid.org/0000-0002-0567-4616)
- Н В Стуров (ORCID: https://orcid.org/0000-0002-3138-8410)
- М В Прохорова (ORCID: https://orcid.org/0009-0004-8848-0674)
- Alexander Morozov (ORCID: https://orcid.org/0000-0003-0516-0356)
- Nikolay Vorobyev (ORCID: https://orcid.org/0000-0003-2040-0493)
Institutions
- Peoples' Friendship University of Russia (RU)
- Sechenov University (RU)
- Pirogov Russian National Research Medical University (RU)
- Ministry of Health of the Russian Federation (RU)
- P.A. Hertzen Moscow Oncology Research Institute (RU)
- Federal Medical-Biological Agency (RU)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3389/fphar.2024.1503317
- Citations
- 6
- Primary Topic
- Pomegranate: compositions and health benefits
- Type
- article
- Field-Weighted Citation Impact
- 6.72